Results 161 to 170 of about 10,941,841 (309)

AJER ISSUE 4

AJER ISSUE ...
openaire   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Erratum to 'Recent Survival Gains in Stage IV NSCLC by Sociodemographic Strata' [JTO Clinical and Research Reports Volume 6 Issue 4 (2025) 100798]. [PDF]

JTO Clin Res Rep
Ayoade OF, Canavan ME, Zolfaghari EJ, Caturegli G, Kim SY, Boffa DJ.   +5 more
europepmc   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

Complete Issue Volume 13 Issue 4

Journal of the Scholarship of Teaching and Learning, 2013
Editor Journal of the Scholarship of Teaching and Learning
doaj  

Corrigendum to "Overview of mechanisms related to citrulline malate supplementation and different methods of high-intensity interval training on sports performance: A narrative review" [Volume 11, Issue 4, 28 February 2025, e42649]. [PDF]

Heliyon
Nobari H, Samadian L, Saedmocheshi S, Prieto-González P, MacDonald C.   +4 more
europepmc   +1 more source

v. 68, issue 4, October 15, 1999 [PDF]

, 1999

core   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Corrigendum to 'Factors Associated with Adoption of Immune Checkpoint Inhibitor Treatment for Advanced Melanoma: A SEER-Medicare Cohort Study' JID Innovations, Volume 4, Issue 4, July 2024, 100289. [PDF]

JID Innov
Mohr C, Liao K, Hinkston CL, Wehner MR, Li M.   +4 more
europepmc   +1 more source

v. 70, issue 4, October 18, 2002 [PDF]

, 2002

core   +1 more source